Winobin®

Vinorelbine

Product Information

  • Proprietary Name: Winobin®
  • Generic Name: Vinorelbine
  • Dosage Form: Vial and Soft Gelatine Capsule
  • Strengths: 10 mg/1ml, 50 mg/5 ml, 20 mg, 30 mg
  • Indications: Non-Small Cell Lung Cancer, Advanced breast cancer

Oncology

Winobin®

Vinorelbine is indicated for the treatment of non-small cell lung cancer, and advanced breast cancer.

Ready to get started?

Curious about a specific position? Sign up for it.
© NanoAlvand. All rights reserved. Powered by ِDGN.